Left Atrial Appendage Occlusion in Patients with Failure of Antithrombotic Therapy: Good Vibes from Early Studies

Alberto Preda1, Matteo Baroni1, Marisa Varrenti1

  • 1Cardio-Thoraco-Vascular Department, Electrophysiology Unit, ASST Grande Ospedale Metropolitano Niguarda, 20162 Milan, Italy.

PubMed

Insights

Atrial fibrillation (AF) is a common heart rhythm disorder that increases the risk of cardioembolic events, including stroke. Understanding AF

Area of Science:

  • Cardiology and Electrophysiology
  • Neurology
  • Vascular Medicine

Background:

  • Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia.
  • AF significantly elevates the risk of cardioembolic (CE) events, such as ischemic stroke, transient ischemic attack (TIA), and systemic embolism.
  • Effective management of AF is crucial for preventing CE events.

Discussion:

  • The pathophysiology linking AF to CE involves complex hemodynamic and electrophysiological changes.
  • Risk stratification models are essential for identifying patients with AF who are most vulnerable to CE.
  • Anticoagulant therapy remains a cornerstone in AF management to mitigate stroke risk.

Key Insights:

  • AF's high prevalence underscores its public health significance.
  • The direct correlation between AF and CE necessitates proactive clinical strategies.
  • Research continues to refine understanding of AF-related thromboembolism.

Outlook:

  • Future research may focus on novel therapeutic targets for AF and CE prevention.
  • Advancements in diagnostic tools could improve early detection and risk assessment in AF patients.
  • Personalized medicine approaches may optimize treatment strategies for AF-induced cardioembolic risk.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
11
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
26
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
15
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
12
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
767